Proof-of-concept SHEPHERD study will assess SUL-238's effects on mitochondrial function in patients with Parkinson's disease.
Coya is currently conducting the ALSTARS Trial, a Phase 2, randomized, multi-center, double-blind, placebo-controlled study to evaluate the efficacy and safety of COYA 302 for the treatment of ALS ( ...
Just ahead of WWDC, Google's fresh benchmarks for the Chrome browser have revealed impressive speed boosts when optimized on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results